Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Goal Attainment Scaling in Upper Limb Spasticity Treatment

Goal Attainment Scaling in Upper Limb Spasticity Treatment With Botulinum Toxin and the Influence of Regular Exercise for Spastic Upper Limb on Quality of Life in Patients After Stroke

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Patients after stroke with upper limb spasticity treated with botulinum toxin-A (BTX-A) will be included in this two-part study. In the first part, goal attainment scaling and comprehensive assessment of motor functioning will be performed before BTX-A application and after two weeks. In the second part, the patients will be randomised into a test group performing prescribed regular exercise for two weeks and a control group exercising at their own discretion during the same period, whereby the patients' health-related quality of life will be assessed at the beginning and end of the two-week period.

Who May Be Eligible (Plain English)

Who May Qualify: - patient's or caregiver's approval - ischemic or hemorrhagic stroke diagnosed using head CT/MRI - at least one upper limb muscle spasticity (MAS ≥ 3) - candidate for BTX-A treatment or already given BTX-A in the past - patient's or caregiver's capability for goal attainment protocol cooperation (Mini Mental Examination ≥ 24 points) Who Should NOT Join This Trial: - aphasic patients without caregiver's presence - other neurological or musculoskeletal diseases that could affect the treatment outcome Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * patient's or caregiver's approval * ischemic or hemorrhagic stroke diagnosed using head CT/MRI * at least one upper limb muscle spasticity (MAS ≥ 3) * candidate for BTX-A treatment or already given BTX-A in the past * patient's or caregiver's capability for goal attainment protocol cooperation (Mini Mental Examination ≥ 24 points) Exclusion Criteria: * aphasic patients without caregiver's presence * other neurological or musculoskeletal diseases that could affect the treatment outcome

Treatments Being Tested

BEHAVIORAL

Prescribed exercise program

Active or passive exercises for the spastic upper limb, including functional electrical stimulation (FES), performed regularly for two weeks.

Locations (1)

University Rehabilitation Institute, Republic of Slovenia
Ljubljana, Slovenia